Polysomnographic Analysis of a Pediatric Case of Baclofen-Induced Central Sleep Apnea

J Clin Sleep Med. 2019 Feb 15;15(2):351-354. doi: 10.5664/jcsm.7644.

Abstract

Respiratory disorders may follow brain injury and may also occur because of comorbidities and drug use, especially central depressants or muscle relaxants. Sleep can precipitate respiratory disorders, thus polysomnography can be a powerful diagnostic tool. By revealing breathing patterns that identify specific sleep disorders, polysomnography may unmask adverse pharmacological effects, for instance connecting central depressant drugs with central sleep apneas. We describe the case of a pediatric patient in rehabilitation from brain injury who developed a central sleep apnea following a baclofen dose increase within the therapeutic range, while assuming an under-dosed benzodiazepine. Polysomnography identified a typical respiration pattern, previously observed in adults treated with baclofen and other central depressants. Baclofen tapering resolved the central sleep apnea. Polysomnography, and this specific pattern, may be proposed as diagnostic tools in patients with high dose baclofen that can be used to prevent potential respiratory disorders in children.

Keywords: baclofen; pediatric; polysomnography; rehabilitation; sleep-disordered breathing.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Baclofen / administration & dosage
  • Baclofen / adverse effects*
  • Child
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Injections, Spinal
  • Polysomnography* / drug effects
  • Sleep Apnea, Central / chemically induced*
  • Sleep Apnea, Central / diagnosis

Substances

  • Baclofen